We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+28.39%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
+$953M
Cap. Flow
+$556M
Cap. Flow %
10.99%
Top 10 Hldgs %
34.58%
Holding
150
New
52
Increased
21
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$116M
2
ONCR
Oncorus, Inc.
ONCR
+$66M
3
TOI icon
The Oncology Institute
TOI
+$56.2M
4
CYTK icon
Cytokinetics
CYTK
+$45M
5
VTRS icon
Viatris
VTRS
+$40M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$196M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$142M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$96M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$74.4M
5
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$58.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.84%
2 Industrials 0.55%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
101
Arvinas
ARVN
$526M
$6.37M 0.13%
75,000
-539,156
-88% -$18.6M
FDMT icon
102
4D Molecular Therapeutics
FDMT
$498M
$6.22M 0.12%
+150,000
New +$6.19M
XENT
103
DELISTED
Intersect ENT, Inc
XENT
$5.85M 0.12%
255,456
-1,318,078
-84% -$25.1M
CABA icon
104
Cabaletta Bio
CABA
$439M
$5.79M 0.11%
464,252
– –
EAR
105
DELISTED
Eargo, Inc. Common Stock
EAR
$5.6M 0.11%
+6,250
New +$5.27M
CHFW.U
106
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$5.24M 0.1%
+500,000
New +$5.11M
LGVW.WS
107
DELISTED
Longview Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Clas
LGVW.WS
$4.83M 0.1%
+733,333
New +$1.86M
MASS icon
108
908 Devices
MASS
$313M
$4.27M 0.08%
+75,000
New +$4.38M
MTCR
109
DELISTED
Metacrine, Inc. Common Stock
MTCR
$2.18M 0.04%
277,469
-650,000
-70% -$5.96M
VCEL icon
110
Vericel Corp
VCEL
$2.36B
$2.01M 0.04%
64,946
-1,425,172
-96% -$33.9M
FUSN
111
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.91M 0.04%
162,378
-809,668
-83% -$10.2M
CEREW
112
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$942K 0.02%
+166,666
New +$672K
NEOS
113
DELISTED
Neos Therapeutics, Inc
NEOS
$201K ﹤0.01%
320,993
– –
WINT
114
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
ADCT icon
115
ADC Therapeutics
ADCT
$140M
– –
-300,000
Closed -$9.9M
LONA
116
LeonaBio Inc
LONA
$65.8M
– –
-45,000
Closed -$8.31M
CERS icon
117
Cerus
CERS
$577M
– –
-85,143
Closed -$533K
EHTH icon
118
eHealth
EHTH
$42.2M
– –
-333,411
Closed -$26.3M
GKOS icon
119
Glaukos
GKOS
$9.29B
– –
-695,523
Closed -$34.4M
GOCO
120
DELISTED
GoHealth
GOCO
– –
-46,667
Closed -$9.12M
HOLX
121
DELISTED
Hologic
HOLX
– –
-388,000
Closed -$25.8M
NNOX icon
122
Nano X Imaging
NNOX
$64.5M
– –
-762,000
Closed -$17.9M
NTRA icon
123
Natera
NTRA
$36.2B
– –
-208,333
Closed -$15.1M
SLQT icon
124
SelectQuote
SLQT
$125M
– –
-750,000
Closed -$15.2M
VKTX icon
125
Viking Therapeutics
VKTX
$3.86B
– –
-348,441
Closed -$2.03M
2 3 4
5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2020 Portfolio in Review

As of Q4 2020, Deerfield Management held 150 positions worth $5.06B, up 23% from $4.11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management deployed $556M of net new capital in Q4 2020, opening 52 new positions and adding to 21 existing holdings. Its largest new stake was Biogen: 448,000 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was DFP Healthcare Acquisitions Corp. Unit, an estimated $58.3M trimmed.

  • Deerfield Management's largest Q4 2020 buy was Biogen: 448,000 shares worth $110M.
  • Deerfield Management added most to Viatris in Q4 2020, an estimated $40M increase.
  • Deerfield Management's biggest Q4 2020 reduction was DFP Healthcare Acquisitions Corp. Unit, cutting an estimated $58.3M.
  • Deerfield Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $196M.
  • Deerfield Management's ten largest holdings make up 35% of its $5.06B portfolio in Q4 2020.
  • Deerfield Management opened 52 new positions and closed 24 in Q4 2020.
  • Deerfield Management's portfolio value rose 23% quarter-over-quarter to $5.06B.

Based on Deerfield Management's 13F filing for Q4 2020, filed 16 Feb 2021.